These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11775935)

  • 41. New pediatric dosing recommendations for atazanavir.
    AIDS Patient Care STDS; 2008 Apr; 22(4):347. PubMed ID: 18434948
    [No Abstract]   [Full Text] [Related]  

  • 42. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P; Likanonsakul S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report from the 15th Retrovirus Conference. Expanding HIV treatment options during pregnancy.
    Henry K
    AIDS Clin Care; 2008 Apr; 20(4):30-1. PubMed ID: 19271265
    [No Abstract]   [Full Text] [Related]  

  • 44. Focus on fat.
    TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
    [No Abstract]   [Full Text] [Related]  

  • 45. Updated guidelines for occupational postexposure prophylaxis.
    del Rio C
    AIDS Clin Care; 2005 Dec; 17(12):114. PubMed ID: 16388540
    [No Abstract]   [Full Text] [Related]  

  • 46. DHHS issues adult guideline revisions.
    Bartlett JG;
    Hopkins HIV Rep; 2004 Jan; 16(1):1, 5. PubMed ID: 14989190
    [No Abstract]   [Full Text] [Related]  

  • 47. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
    Gupta Samir K
    AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
    [No Abstract]   [Full Text] [Related]  

  • 49. Substitution for protease inhibitors in HIV therapy.
    Mikhail E
    N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602
    [No Abstract]   [Full Text] [Related]  

  • 50. Once-daily therapies.
    Carey D
    J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simplifying suppression: switching therapies to improve HIV disease management.
    Moyle GJ
    AIDS Read; 2004 Jul; 14(7):380-4. PubMed ID: 15282867
    [No Abstract]   [Full Text] [Related]  

  • 52. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
    Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
    AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
    [No Abstract]   [Full Text] [Related]  

  • 53. Protease inhibitor boosting is complex, requires thorough knowledge of interactions.
    Monier P
    HIV Clin; 2004; 16(3):1-3. PubMed ID: 15366104
    [No Abstract]   [Full Text] [Related]  

  • 54. Report from ICAAC: new drugs and antiretroviral therapy for naïve patients.
    Gallant JE
    Hopkins HIV Rep; 2002 Nov; 14(6):1-3, 7. PubMed ID: 12491989
    [No Abstract]   [Full Text] [Related]  

  • 55. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Introduction.
    TreatmentUpdate; 2003; 15(3):1. PubMed ID: 17216843
    [No Abstract]   [Full Text] [Related]  

  • 56. "What you lookin' at?".
    Gormley F
    GMHC Treat Issues; 2001 May; 15(5):5-6. PubMed ID: 11548302
    [No Abstract]   [Full Text] [Related]  

  • 57. Report from the 12th Retrovirus Conference. Adherence.
    Friedland GH; Nagy GS
    AIDS Clin Care; 2005 Apr; 17(4):36. PubMed ID: 15875309
    [No Abstract]   [Full Text] [Related]  

  • 58. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes.
    Albrecht H
    J Watch AIDS Clin Care; 2009 Oct; 21(10):82. PubMed ID: 20458813
    [No Abstract]   [Full Text] [Related]  

  • 59. Antiretroviral therapy update from the 44th ICAAC.
    Gallant JE
    Hopkins HIV Rep; 2005 Jan; 17(1):1-3, 7. PubMed ID: 16419298
    [No Abstract]   [Full Text] [Related]  

  • 60. From the Infectious Diseases Society of America (IDSA) meeting - important new findings in HIV treatment and pathogenesis, 2003.
    Karakousis PC; Page KR; Bishai WR
    Hopkins HIV Rep; 2004 Jan; 16(1):2-3. PubMed ID: 14989191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.